
- Telehealth visits
- Insurance plan information

Anne Arnhym, NP, MSN
Urology • Pediatric Urology- Telehealth visits
- Insurance plan information



Anne Arnhym, NP, MSN
Urology • Pediatric Urology- Telehealth visits
- Insurance plan information
On this page
About me
Anne Arnhym is a pediatric nurse practitioner who specializes in caring for children with bladder and bowel dysfunction as well as those with neurogenic bladder, posterior urethral valve and bladder exstrophy. She has expertise in performing diagnostic urological procedures, such as complex urodynamics testing to assess bladder function.
Arnhym earned her master's degree in nursing from UCSF. She serves as volunteer faculty at the UCSF School of Nursing as a regular guest lecturer and preceptor (training guide and mentor).
Arnhym co-authored A Guide to Treating Your Child's Daytime or Nighttime Accidents, Urinary Tract Infections and Constipation, an educational booklet on bladder and bowel problems in otherwise healthy children. Most recently, she co-authored an article, published in the Journal of Pediatric Urology, on using telemedicine to manage the care of children with bladder and bowel dysfunction.
Education & training
Board certification
- Pediatric Primary Care Nurse Practitioner, Pediatric Nursing Certification Board (PNCB)
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221171%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221171%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
